107 related articles for article (PubMed ID: 17720699)
21. The role of glycodelin in cell differentiation and tumor growth.
Koistinen H; Hautala LC; Seppälä M; Stenman UH; Laakkonen P; Koistinen R
Scand J Clin Lab Invest; 2009; 69(4):452-9. PubMed ID: 19551557
[TBL] [Abstract][Full Text] [Related]
22. Effect of normal endometrial stroma on growth and differentiation in Ishikawa endometrial adenocarcinoma cells.
Arnold JT; Lessey BA; Seppälä M; Kaufman DG
Cancer Res; 2002 Jan; 62(1):79-88. PubMed ID: 11782363
[TBL] [Abstract][Full Text] [Related]
23. Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma.
Heider U; von Metzler I; Kaiser M; Rosche M; Sterz J; Rötzer S; Rademacher J; Jakob C; Fleissner C; Kuckelkorn U; Kloetzel PM; Sezer O
Eur J Haematol; 2008 Feb; 80(2):133-42. PubMed ID: 18005386
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of lymphangiogenic factor VEGF-C expression and production by the histone deacetylase inhibitor suberoylanilide hydroxamic acid in breast cancer cells.
Cheng HT; Hung WC
Oncol Rep; 2013 Mar; 29(3):1238-44. PubMed ID: 23242251
[TBL] [Abstract][Full Text] [Related]
25. Activity of suberoylanilide hydroxamic Acid against human breast cancer cells with amplification of her-2.
Bali P; Pranpat M; Swaby R; Fiskus W; Yamaguchi H; Balasis M; Rocha K; Wang HG; Richon V; Bhalla K
Clin Cancer Res; 2005 Sep; 11(17):6382-9. PubMed ID: 16144943
[TBL] [Abstract][Full Text] [Related]
26. Glycodelin blocks progression to S phase and inhibits cell growth: a possible progesterone-induced regulator for endometrial epithelial cell growth.
Ohta K; Maruyama T; Uchida H; Ono M; Nagashima T; Arase T; Kajitani T; Oda H; Morita M; Yoshimura Y
Mol Hum Reprod; 2008 Jan; 14(1):17-22. PubMed ID: 18178606
[TBL] [Abstract][Full Text] [Related]
27. The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL.
Butler LM; Liapis V; Bouralexis S; Welldon K; Hay S; Thai le M; Labrinidis A; Tilley WD; Findlay DM; Evdokiou A
Int J Cancer; 2006 Aug; 119(4):944-54. PubMed ID: 16550602
[TBL] [Abstract][Full Text] [Related]
28. SAHA, a HDAC inhibitor, has profound anti-growth activity against non-small cell lung cancer cells.
Komatsu N; Kawamata N; Takeuchi S; Yin D; Chien W; Miller CW; Koeffler HP
Oncol Rep; 2006 Jan; 15(1):187-91. PubMed ID: 16328054
[TBL] [Abstract][Full Text] [Related]
29. Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients.
Sonnemann J; Gänge J; Pilz S; Stötzer C; Ohlinger R; Belau A; Lorenz G; Beck JF
BMC Cancer; 2006 Jul; 6():183. PubMed ID: 16834771
[TBL] [Abstract][Full Text] [Related]
30. c-Myc overexpression sensitizes Bim-mediated Bax activation for apoptosis induced by histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through regulating Bcl-2/Bcl-xL expression.
Jiang X; Tsang YH; Yu Q
Int J Biochem Cell Biol; 2007; 39(5):1016-25. PubMed ID: 17331788
[TBL] [Abstract][Full Text] [Related]
31. Endometrial receptivity and the window of implantation.
Lessey BA
Baillieres Best Pract Res Clin Obstet Gynaecol; 2000 Oct; 14(5):775-88. PubMed ID: 11023799
[TBL] [Abstract][Full Text] [Related]
32. Glycodelin: a reproduction-related lipocalin.
Halttunen M; Kämäräinen M; Koistinen H
Biochim Biophys Acta; 2000 Oct; 1482(1-2):149-56. PubMed ID: 11058757
[TBL] [Abstract][Full Text] [Related]
33. Suberoylanilide hydroxamic acid enhances gap junctional intercellular communication via acetylation of histone containing connexin 43 gene locus.
Ogawa T; Hayashi T; Tokunou M; Nakachi K; Trosko JE; Chang CC; Yorioka N
Cancer Res; 2005 Nov; 65(21):9771-8. PubMed ID: 16266998
[TBL] [Abstract][Full Text] [Related]
34. Induction of apoptosis in renal tubular cells by histone deacetylase inhibitors, a family of anticancer agents.
Dong G; Wang L; Wang CY; Yang T; Kumar MV; Dong Z
J Pharmacol Exp Ther; 2008 Jun; 325(3):978-84. PubMed ID: 18310471
[TBL] [Abstract][Full Text] [Related]
35. SAHA regulates histone acetylation, Butyrylation, and protein expression in neuroblastoma.
Xu G; Wang J; Wu Z; Qian L; Dai L; Wan X; Tan M; Zhao Y; Wu Y
J Proteome Res; 2014 Oct; 13(10):4211-9. PubMed ID: 25160476
[TBL] [Abstract][Full Text] [Related]
36. Expression of the glycodelin A gene and the detection of its protein in tissues and serum of ovarian carcinoma patients.
Richter C; Baetje M; Bischof A; Makovitzky J; Richter DU; Gerber B; Briese V
Anticancer Res; 2007; 27(4A):2023-5. PubMed ID: 17649816
[TBL] [Abstract][Full Text] [Related]
37. Anti-estrogenic actions of histone deacetylase inhibitors in MCF-7 breast cancer cells.
De los Santos M; Martínez-Iglesias O; Aranda A
Endocr Relat Cancer; 2007 Dec; 14(4):1021-8. PubMed ID: 18045953
[TBL] [Abstract][Full Text] [Related]
38. The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin.
Butler LM; Zhou X; Xu WS; Scher HI; Rifkind RA; Marks PA; Richon VM
Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11700-5. PubMed ID: 12189205
[TBL] [Abstract][Full Text] [Related]
39. Suberoylanilide hydroxamic acid enhances odontoblast differentiation.
Kwon A; Park HJ; Baek K; Lee HL; Park JC; Woo KM; Ryoo HM; Baek JH
J Dent Res; 2012 May; 91(5):506-12. PubMed ID: 22447851
[TBL] [Abstract][Full Text] [Related]
40. SAHA treatment reveals the link between histone lysine acetylation and proteome in nonsmall cell lung cancer A549 Cells.
Wu Q; Xu W; Cao L; Li X; He T; Wu Z; Li W
J Proteome Res; 2013 Sep; 12(9):4064-73. PubMed ID: 23909948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
